EXHIBIT 2028
`
`EXHIBIT 2028
`
`
`
`

`
`Paper No.
`Paper No. (cid:9)
`
`
`
`Filed on behalf of: Mylan Pharmaceuticals, Inc.
`Filed on behalf of: Mylan Pharmaceuticals, Inc.
`By: (cid:9)
`Steven W. Parmelee
`By: (cid:9)
`Steven W. Parmelee
`Michael T. Rosato
`Michael T. Rosato
`WILSON SONSINI GOODRICH & ROSATI
`WILSON SONSINI GOODRICH & ROSATI
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Fax: 206-883-2699
`Email: sparmelee@wsgr.com
`Email: sparmelee@wsgr.com
`Email: mrosato@wsgr.com
`Email: mrosato@wsgr.corn
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS, INC. and
`MYLAN PHARMACEUTICALS, INC. and
`MYLAN LABORATORIES LIMITED,
`MYLAN LABORATORIES LIMITED,
`Petitioners,
`Petitioners,
`
`v.
`v.
`
`BAXTER INTERNATIONAL INC.,
`BAXTER INTERNATIONAL INC.,
`Patent Owner.
`Patent Owner.
`
`Patent No. 6,528,540
`Patent No. 6,528,540
`
`PETITIONER MYLAN PHARMACEUTICALS, INC.'S
`PETITIONER MYLAN PHARMACEUTICALS, INC.'S
`POWER OF ATTORNEY
`POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`Pursuant to 37 C.F.R. § 42.10(a) and (b), Petitioner, Mylan Pharmaceuticals,
`Pursuant to 37 C.F.R. § 42.10(a) and (b), Petitioner, Mylan Pharmaceuticals,
`
`Inc., hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`Inc., hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`
`Rosati, Customer Number 21971, including the following lead and back-up
`Rosati, Customer Number 21971, including the following lead and back-up
`
`counsel, as its attorneys to transact all business in the United States Patent &
`counsel, as its attorneys to transact all business in the United States Patent &
`
`Trademark Office associated with a petition for inter partes review of U.S. Patent
`Trademark Office associated with a petition for inter partes review of U.S. Patent
`
`No. 6,528,540:
`No. 6,528,540:
`
`Back-Up Counsel
`Back-Up Counsel
`Lead Counsel
`Lead Counsel
`Michael T. Rosato
`Michael T. Rosato
`Steven W. Parmelee
`Steven W. Parmelee
`USPTO Reg. No. 52,182
`USPTO Reg. No. 52,182
`USPTO Reg. No. 31,990
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH WILSON SONSINI GOODRICH
`WILSON SONSINI GOODRICH WILSON SONSINI GOODRICH
`& ROSATI
`& ROSATI
`& ROSATI
`& ROSATI
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`Tel.: 206-883-2529
`Tel.: 206-883-2542
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Fax: 206-883-2699
`Fax: 206-883-2699
`Fax: 206-883-2699
`Email: mrosato@wsgr.com
`Email: mrosato@wsgr.com
`Email: sparmelee@wsgr.com
`Email: sparmelee@wsgr.com
`
`By:
`By: .41if
`ylan Pharmaceuticals, Inc.
`ylan Pharmaceuticals, Inc.
`For:
`For:
`
`:e"
`e: (cid:9)
`Na e: (cid:9)
`Title:
`Title:
`
`Date:
`Date:
`
`
`
`
`1-
`-1-
`
`Bradley Wideman
`
`Vice President and General Counsel Securities and Secretary
`
`November 18, 2015
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`Paper No. (cid:9)
`Paper No. (cid:9)
`
`
`
`
`Filed on behalf of: Mylan Pharmaceuticals, Inc.
`Filed on behalf of: Mylan Pharmaceuticals, Inc.
`Steven W. Parmelee
`Steven W. Parmelee
`By: (cid:9)
`By: (cid:9)
`Michael T. Rosato
`Michael T. Rosato
`WILSON SONSINI GOODRICH & ROSATI
`WILSON SONSINI GOODRICH & ROSATI
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Fax: 206-883-2699
`Email: sparmelee@wsgr.com
`Email: sparmelee@wsgr.com
`Email: mrosato@wsgr.com
`Email: mrosato@wsgr.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS, INC. and
`MYLAN PHARMACEUTICALS, INC. and
`MYLAN LABORATORIES LIMITED,
`MYLAN LABORATORIES LIMITED,
`Petitioners,
`Petitioners,
`
`v.
`v.
`
`BAXTER INTERNATIONAL INC.,
`BAXTER INTERNATIONAL INC.,
`Patent Owner.
`Patent Owner.
`
`Patent No. 6,310,094
`Patent No. 6,310,094
`
`PETITIONER MYLAN PHARMACEUTICALS, INC.'S
`PETITIONER MYLAN PHARMACEUTICALS, INC.'S
`POWER OF ATTORNEY
`POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`Pursuant to 37 C.F.R. § 42.10(a) and (b), Petitioner, Mylan Pharmaceuticals,
`Pursuant to 37 C.F.R. § 42.10(a) and (b), Petitioner, Mylan Pharmaceuticals,
`
`Inc., hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`Inc., hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`
`Rosati, Customer Number 21971, including the following lead and back-up
`Rosati, Customer Number 21971, including the following lead and back-up
`
`counsel, as its attorneys to transact all business in the United States Patent &
`counsel, as its attorneys to transact all business in the United States Patent &
`
`Trademark Office associated with a petition for inter partes review of U.S. Patent
`Trademark Office associated with a petition for inter partes review of U.S. Patent
`
`No. 6,310,094:
`No. 6,310,094:
`
`Back-Up Counsel
`Back-Up Counsel
`Lead Counsel
`Lead Counsel
`Michael T. Rosato
`Michael T. Rosato
`Steven W. Parmelee
`Steven W. Parmelee
`USPTO Reg. No. 52,182
`USPTO Reg. No. 52,182
`USPTO Reg. No. 31,990
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH WILSON SONSINI GOODRICH
`WILSON SONSINI GOODRICH WILSON SONSINI GOODRICH
`& ROSATI
`& ROSATI
`& ROSATI
`& ROSATI
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`Tel.: 206-883-2529
`Tel.: 206-883-2542
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Fax: 206-883-2699
`Fax: 206-883-2699
`Fax: 206-883-2699
`Email: mrosato@wsgr.com
`Email: mrosato@wsgr.com
`Email: sparmelee@wsgr.com
`Email: sparmelee@wsgr.com
`
`
`
`
`
`
`
`By: (cid:9)
`By: (cid:9)
`Fo
`Fo
`
`Name: (cid:9)
`Name: (cid:9)
`Title: (cid:9)
`Title: (cid:9)
`
`Date: (cid:9)
`Date: (cid:9)
`
`an Pharmaceuticals, Inc.
`an Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`-1-
`-1-
`
`Vice President and General Counsel Securities and Secretary
`
`Bradley Wideman
`
`November 18, 2015
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Paper No. Paper No.
`
`
`Filed on behalf of: Mylan Pharmaceuticals Inc. Filed on behalf of: Mylan Pharmaceuticals Inc.
`
`By: (cid:9)By: (cid:9)
`
`Steven W. Parmelee Steven W. Parmelee
`
`Michael T. Rosato Michael T. Rosato
`
`WILSON SONSINI GOODRICH & ROSATI WILSON SONSINI GOODRICH & ROSATI
`
`701 Fifth Avenue, Suite 5100 701 Fifth Avenue, Suite 5100
`
`Seattle, WA 98104-7036 Seattle, WA 98104-7036
`
`Tel.: 206-883-2542 Tel.: 206-883-2542
`
`Fax: 206-883-2699 Fax: 206-883-2699
`
`Email: sparmelee@wsgr.com Email: sparmelee@wsgr.com
`
`Email: mrosato@wsgr.com Email: mrosato@wsgr.com
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC., MYLAN PHARMACEUTICALS INC.,
`
`
`
`Petitioner, Petitioner,
`
`
`
`v. v.
`
`
`
`ASTRAZENECA AB, ASTRAZENECA AB,
`
`
`
`Patent Owner. Patent Owner.
`
`
`
`Patent No. RE44,186 Patent No. RE44,186
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC.'S PETITIONER MYLAN PHARMACEUTICALS INC.'S
`
`POWER OF ATTORNEY POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc., Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc.,
`
`
`
`hereby appoints the practitioners associated with Wilson Sonsini Goodrich & hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`
`
`
`Rosati, Customer Number 23-2415, including the following lead and back-up Rosati, Customer Number 23-2415, including the following lead and back-up
`
`
`
`counsel, as its attorneys to transact all business in the United States Patent & counsel, as its attorneys to transact all business in the United States Patent &
`
`
`
`Trademark Office associated with a petition for inter partes review of U.S. Patent Trademark Office associated with a petition for inter partes review of U.S. Patent
`
`
`
`No. RE44,186: No. RE44,186:
`
`Lead Counsel Lead Counsel
`
`
`Back-Up Counsel Back-Up Counsel
`
`Steven W. Parmelee Steven W. Parmelee
`
`Michael T. Rosato Michael T. Rosato
`
`USPTO Reg. No. 31,990 USPTO Reg. No. 31,990
`
`USPTO Reg. No. 52,182 USPTO Reg. No. 52,182
`
`WILSON SONSINI GOODRICH & WILSON SONSINI GOODRICH & WILSON SONSINI GOODRICH & WILSON SONSINI GOODRICH &
`
`ROSATI ROSATI
`
`ROSATI ROSATI
`
`701 Fifth Avenue 701 Fifth Avenue
`
`701 Fifth Avenue 701 Fifth Avenue
`
`Suite 5100 Suite 5100
`
`Suite 5100 Suite 5100
`
`Seattle, WA 98104-7036 Seattle, WA 98104-7036
`
`Seattle, WA 98104-7036 Seattle, WA 98104-7036
`
`Tel.: 206-883-2529 Tel.: 206-883-2529
`
`Tel.: 206-883-2542 Tel.: 206-883-2542
`
`Fax: 206-883-2699 Fax: 206-883-2699
`
`Fax: 206-883-2699 Fax: 206-883-2699
`
`Email: mrosato@wsgr.com Email: mrosato@wsgr.com
`
`Email: sparmelee@wsgr.com Email: sparmelee@wsgr.com
`
`
`By: By:
`
`For: P For: P
`
`
`
`—o —o
`
`
`
`an Pharmaceuticals Inc. an Pharmaceuticals Inc.
`
`
`Bradley L. Wideman Bradley L. Wideman
`
`Na Na
`
`Title: Secretary Title: Secretary
`
`
`
`Date: (4 9-0/5 Date: (4 9-0/5
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`(cid:9)
`(cid:9)
`(cid:9)
`(cid:9)
`(cid:9)
`(cid:9)
`

`
`Paper No. (cid:9)
`Paper No. (cid:9)
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.
`MYLAN PHARMACEUTICALS INC.
`Petitioner
`Petitioner
`
`v.
`v.
`
`YEDA RESEARCH & DEVELOPMENT CO. LTD.
`YEDA RESEARCH & DEVELOPMENT CO. LTD.
`Patent Owner
`Patent Owner
`
`Patent No. 8,969,302
`Patent No. 8,969,302
`
`PETITIONER MYLAN PHARMACEUTICALS INC.
`PETITIONER MYLAN PHARMACEUTICALS INC.
`POWER OF ATTORNEY
`POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc.,
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc.,
`
`hereby appoints the following practitioners as its attorneys to act on its behalf in all
`hereby appoints the following practitioners as its attorneys to act on its behalf in all
`
`matters associated with the petition for inter partes review of U.S. Patent No.
`matters associated with the petition for inter partes review of U.S. Patent No.
`
`8,969,302, with full power to appoint an associate agent and to transact all business
`8,969,302, with full power to appoint an associate agent and to transact all business
`
`in the United States Patent & Trademark Office in connection therewith:
`in the United States Patent & Trademark Office in connection therewith:
`
`Lead Counsel
`Lead Counsel
`Jeffrey W. Guise,
`Jeffrey W. Guise,
`USPTO Reg. No. 34,613
`USPTO Reg. No. 34,613
`WILSON SONSINI GOODRICH &
`WILSON SONSINI GOODRICH &
`ROSATI
`ROSATI
`650 Page Mill Road,
`650 Page Mill Road,
`Palo Alto, CA 94304
`Palo Alto, CA 94304
`Tel.: 858-350-2300
`Tel.: 858-350-2300
`Fax: 858-350-2399
`Fax: 858-350-2399
`Email: jguise@wsgr.com
`Email: jguise@wsgr.com
`
`Back-Up Counsel
`Back-Up Counsel
`Brandon White
`Brandon White
`USPTO Reg. No. 52,354
`USPTO Reg. No. 52,354
`PERKINS COIE
`PERKINS COIE
`700 13th Street, NW, Suite 600
`700 13th Street, NW, Suite 600
`Washington, D.C. 20005-3960
`Washington, D.C. 20005-3960
`Tel.: 202-654-6206
`Tel.: 202-654-6206
`Fax: 202-654-6211
`Fax: 202-654-6211
`BMWhite@perkinscoie.com
`BMWhite@perkinscoie.com
`
`By:
`By:
`
`For: P
`For: P
`
`Nam
`Nam
`
`Title:
`Title:
`Date: (cid:9)
`Date: (cid:9)
`
`,V3//5—
`,V3//5—
`
`rmaceuticals Inc.
`rmaceuticals Inc.
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Paper No. (cid:9)Paper No. (cid:9)
`
`
`
`
`
`
`
`UNITED STATES PA PENT AND TRADEMARK OFFICE UNITED STATES PA PENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC. MYLAN PHARMACEUTICALS INC.
`
`Petitioner Petitioner
`
`
`
`v. v.
`
`
`YEDA RESEARCH & DEVELOPMENT CO. L ID. YEDA RESEARCH & DEVELOPMENT CO. L ID.
`
`Patent Owner Patent Owner
`
`
`
`Patent No. 8,399,413 Patent No. 8,399,413
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC. PETITIONER MYLAN PHARMACEUTICALS INC.
`
`POWER OF ATTORNEY POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc., Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc.,
`
`
`
`hereby appoints the following practitioners as its attorneys to act on its behalf in all hereby appoints the following practitioners as its attorneys to act on its behalf in all
`
`
`
`matters associated with the petition for inter partes review of U.S. Patent No. matters associated with the petition for inter partes review of U.S. Patent No.
`
`
`
`8,399,413, with full power to appoint an associate agent and to transact all business 8,399,413, with full power to appoint an associate agent and to transact all business
`
`
`
`in the United States Patent & Trademark Office in connection therewith: in the United States Patent & Trademark Office in connection therewith:
`
`
`Lead Counsel Lead Counsel
`
`Jeffrey W. Guise, Jeffrey W. Guise,
`
`USPTO Reg. No. 34,613 USPTO Reg. No. 34,613
`
`WILSON SONSINI GOODRICH & WILSON SONSINI GOODRICH &
`
`ROSATI ROSATI
`
`650 Page Mill Road, 650 Page Mill Road,
`
`Palo Alto, CA 94304 Palo Alto, CA 94304
`
`Tel.: 858-350-2300 Tel.: 858-350-2300
`
`Fax: 858-350-2399 Fax: 858-350-2399
`
`Email: jguise@wsgr.com Email: jguise@wsgr.com
`
`
`Back-Up Counsel Back-Up Counsel
`
`Brandon White Brandon White
`
`USPTO Reg. No. 52,354 USPTO Reg. No. 52,354
`
`PERKINS COIE PERKINS COIE
`
`700 13th Street, NW, Suite 600 700 13th Street, NW, Suite 600
`
`Washington, D.C. 20005-3960 Washington, D.C. 20005-3960
`
`Tel.: 202-654-6206 Tel.: 202-654-6206
`
`Fax: 202-654-6211 Fax: 202-654-6211
`
`BMWhite@perkinscoie.com BMWhite@perkinscoie.com
`
`
`By: (cid:9)By: (cid:9)
`
`For (cid:9)For (cid:9)
`
`
`Name: (cid:9)Name: (cid:9)
`
`Title: Title:
`
`Date: (cid:9)Date: (cid:9)
`
`
`
`
`an Pharmaceuticals Inc. an Pharmaceuticals Inc.
`
`
`tti,',efhaae? tti,',efhaae?
`
`(cid:9) 5e rr-e y J /11 fa/ (cid:9) 5e rr-e y J /11 fa/
`
`
`
`2 63-7 2 63-7
`
`
`
`-1- -1-
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Paper No. Paper No.
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC. MYLAN PHARMACEUTICALS INC.
`
`Petitioner Petitioner
`
`
`
`v. v.
`
`
`YEDA RESEARCH & DEVELOPMENT CO. LID. YEDA RESEARCH & DEVELOPMENT CO. LID.
`
`Patent Owner Patent Owner
`
`
`
`Patent No. 8,232,250 Patent No. 8,232,250
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC.'S PETITIONER MYLAN PHARMACEUTICALS INC.'S
`
`POWER OF ATTORNEY POWER OF ATTORNEY
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc., Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc.,
`
`
`
`hereby appoints the following practitioners as its attorneys to act on its behalf in all hereby appoints the following practitioners as its attorneys to act on its behalf in all
`
`
`
`matters associated with the petition for inter partes review of U.S. Patent No. matters associated with the petition for inter partes review of U.S. Patent No.
`
`
`
`8,232,250, with full power to appoint an associate agent and to transact all business 8,232,250, with full power to appoint an associate agent and to transact all business
`
`
`
`in the United States Patent & Trademark Office in connection therewith: in the United States Patent & Trademark Office in connection therewith:
`
`
`Lead Counsel Lead Counsel
`
`Jeffrey W. Guise, Jeffrey W. Guise,
`
`USPTO Reg. No. 34,613 USPTO Reg. No. 34,613
`
`WILSON SONSTNI GOODRICH & WILSON SONSTNI GOODRICH &
`
`ROSATI ROSATI
`
`650 Page Mill Road, 650 Page Mill Road,
`
`Palo Alto, CA 94304 Palo Alto, CA 94304
`
`Tel.: 858-350-2300 Tel.: 858-350-2300
`
`Fax: 858-350-2399 Fax: 858-350-2399
`
`Email: jguisewsgr.com Email: jguisewsgr.com
`
`
`Back-Up Counsel Back-Up Counsel
`
`Brandon White Brandon White
`
`USPTO Reg. No. 52,354 USPTO Reg. No. 52,354
`
`PERKINS COIE PERKINS COIE
`
`700 13th Street, NW, Suite 600 700 13th Street, NW, Suite 600
`
`Washington, D.C. 20005-3960 Washington, D.C. 20005-3960
`
`Tel.: 202-654-6206 Tel.: 202-654-6206
`
`Fax: 202-654-6211 Fax: 202-654-6211
`
`BMWhite@perkinscoie.com BMWhite@perkinscoie.com
`
`
`By: By:
`
`For: Petitioner (cid:9)For: Petitioner (cid:9)
`
`
`
`lan Pha aceuticals Inc. lan Pha aceuticals Inc.
`
`
`Name: Name:
`
`Title: Title:
`
`
`
`Date: Date:
`
`
`
`sia e9 sia e9
`
`
`
`0 /5 0 /5
`
`
`
`-1- -1-
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`)
`)
`)
`U.S. Class: 514/170
`) U.S. Class: 514/170
`U.S. Class: 514/170
`)
`Petition No.: TBD
`) Petition No.: TBD
`Petition No.: TBD
`)
`Petition Filed: TBD
`) Petition Filed: TBD
`Petition Filed: TBD
`)
`FILED ELECTRONICALLY
`) FILED ELECTRONICALLY
`FILED ELECTRONICALLY
`PER 37 C.F.R. § 42.6(b)(1)
`) PER 37 C.P.R.§ 42.6(b)(1)
`PER 37 C.F.R. § 42.6(b)(1)
`)
`)
`)
`)
`)
`)
`
`MYLAN PHARMACEUTICALS INC.
`MYLAN PHARMACEUTICALS INC.
`MYLAN PHARMACEUTICALS INC.
`
`(Petitioner)
`(Petitioner)
`(Petitioner)
`v.
`v.
`v.
`
`WARNER-CHILCOTT COMPANY
`WARNER-CHILCOTT COMPANY
`WARNER-CHILCOTT COMPANY
`LLC
`LLC
`LLC
`
`(Patent Owner)
`(Patent Owner)
`(Patent Owner)
`
`Re: U.S. Patent No. 7,704,984
`Re: U.S. Patent No. 7,704,984
`Re: U.S. Patent No. 7,704,984
`Issued: April 27, 2010
`Issued: April27, 2010
`Issued: April 27, 2010
`Inventors: Boissonneault
`Inventors: Boissonneault
`Inventors: Boissonneault
`Application No. 11/112,290
`Application No. 11/112,290
`Application No. 11/112,290
`Filed: April 22, 2005
`Filed: April 22, 2005
`Filed: April 22, 2005
`
`For: EXTENDED ESTROGEN
`For: EXTENDED ESTROGEN
`For: EXTENDED ESTROGEN
`DOSING CONTRACEPTIVE
`DOSING CONTRACEPTIVE
`DOSING CONTRACEPTIVE
`REGIMEN
`REGIMEN
`REGIMEN
`
`Mail Stop Patent Board
`Mail Stop Patent Board
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`Patent Trial and Appeal Board
`Patent Trial and Appeal Board
`U.S.P.T.O.
`U.S.P.T.O.
`U.S.P.T.O.
`P.O. Box 1450
`P.O. Box 1450
`P.O. Box 1450
`Alexandria, VA 22313-1450
`Alexandria, VA 22313-1450
`Alexandria, VA 22313-1450
`
`PETITIONER'S POWER OF ATTORNEY
`PETITIONER'S POWER OF ATTORNEY
`PETITIONER'S POWER OF ATTORNEY
`IN RE PETITION FOR INTER PARTES REVIEW
`IN REPETITION FOR INTER PARTES REVIEW
`IN RE PETITION FOR INTER PARTES REVIEW
`
`Page 1 of 2
`Page 1 of2
`Page 1 of 2
`
`CEPHALON, INC. -- EXHIBIT 2028
`
`

`
`In accordance with 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals
`In accordance with 37 C.F.R. § 42.10(b ), Petitioner, Mylan Pharmaceuticals
`In accordance with 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals
`Inc., hereby appoints the following practitioners as their representative to act on their
`Inc., hereby appoints the following practitioners as their representative to act on their
`Inc., hereby appoints the following practitioners as their representative to act on their
`behalf in the above-identified petition for inter partes review, with full power to
`behalf in the above-identified petition for inter partes review, with full power to
`behalf in the above-identified petition for inter partes review, with full power to
`appoint an associate agent and to transact all business in the United States Patent and
`appoint an associate agent and to transact all business in the United States Patent and
`appoint an associate agent and to transact all business in the United States Patent and
`Trademark Office in connection therewith:
`Trademark Office in connection therewith:
`Trademark Office in connection therewith:
`
`Lead Counsel
`Lead Counsel
`Lead Counsel
`Cedric C.Y. Tan (Reg. No. 56,082)
`Cedric C.Y. Tan (Reg. No. 56,082)
`Cedric C.Y. Tan (Reg. No. 56,082)
`ctan@mcguirewoods.com
`ctan@mcguirewoods.com
`ctan(&mcguirewoods.com
`
`Back-Up Counsel
`Back-Up Counsel
`Back-Up Counsel
`Karen L. Carroll (Reg. No. 50,748)
`Karen L. Carroll (Reg. No. 50,748)
`Karen L. Carroll (Reg. No. 50,748)
`kcarroll@mcguirewoods.com
`kcarroll@mcguirewoods.com
`kcarroWmcguirewoods.com
`
`Postal and Hand-Delivery Address:
`Postal and Hand-Delivery Address:
`Postal and Hand-Delivery Address:
`Mc GUIREWOODS LLP
`McGUIREWOODS LLP
`MCGUIREWOODS LLP
`2001 K Street N.W., Suite 400
`2001 K Street N.W., Suite 400
`2001 K Street N.W., Suite 400
`Washington, D.C. 20006-1040
`Washington, D.C. 20006-1040
`Washington, D.C. 20006-1040
`Telephone No.: (202) 828-2812
`Telephone No.: (202) 828-2812
`Telephone No.: (202) 828-2812
`Facsimile: (202) 828-2977
`Facsimile: (202) 828-2977
`Facsimile: (202) 828-2977
`
`Brie L.B. Buchanan (Reg. No. 58,709)
`Brie L.B. Buchanan (Reg. No. 58, 709)
`Brie L.B. Buchanan (Reg. No. 58,709)
`bbuchanan(&mcguirewoods.com
`bbuchanan@mcguirewoods.com
`bbuchanan(&mcguirewoods.com
`
`Postal and Hand-Delivery Address:
`Postal and Hand-Delivery Address:
`Postal and Hand-Delivery Address:
`MCGUIREWOODS LLP
`McGUIREWOODS LLP
`MCGUIREWOODS LLP
`1230 Peachtree Street, Suite 2100
`1230 Peachtree Street, Suite 2100
`1230 Peachtree Street, Suite 2100
`Atlanta, Georgia 30309
`Atlanta, Georgia 30309
`Atlanta, Georgia 30309
`Telephone No.: (404) 443-5620
`Telephone No.: (404) 443-5620
`Telephone No.: (404) 443-5620
`Facsimile: (404) 443-5757
`Facsimile: (404) 443-5757
`Facsimile: (404) 443-5757
`
`The individual signing below has the authority to execute this document on
`The individual signing below has the authority to execute this document on
`The individual signing below has the authority to execute this document on
`behalf of Petitioner, Mylan Pharmaceuticals Inc.
`behalf of Petitioner, Mylan Pharmaceuticals Inc.
`behalf of Petitioner, Mylan Pharmaceuticals Inc.
`
`Mylan Pharmaceuticals Inc.
`Mylan Pharmaceuticals Inc.
`Mylan Pharmaceuticals Inc.
`
`Signature:
`Signature:
`Signature:
`
`Name:
`Name:
`Name:
`Title: (cid:9)
`Title:
`Title: (cid:9)
`
`etary
`etary
`
`Wideman
`Wideman
`
`Date:
`Date:
`Date:
`
`cd L~ J }5
`)
`o? (cid:9)
`
`--~4-+,~~,~~~
`
`Page 2 of 2
`Page 2 of2
`Page 2 of 2
`
`CEPHALON, INC. -- EXHIBIT 2028